Chemical Compound

Linifanib

CAS Registry Number 796967-16-3
Linifanib chemical structure
Primary Record

Linifanib

In stock
4,201 g
Purity
98.7 %
CAS
796967-16-3

Compound Identifiers & Properties

CAS
796967-16-3
PubChem CID
11485656
SMILES
CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N
Canonical SMILES
Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1

Names & Synonyms

  • Linifanib
  • ABT-869
  • 796967-16-3
  • Linifanib (ABT-869)
  • linifanibum
  • Linifanib (GMP)
  • Linifanib [USAN]
  • ABT 869
  • Aminoindazole, 3
  • ABT869
  • Kinome_532
  • Linifanib [USAN:INN]
  • S1003_Selleck
  • AL-39324
  • ABT-869,Linifanib
  • LINIFANIB [INN]
  • ABT-869(Linifanib)
  • Linifanib (USAN/INN)
  • RefChem:799224
  • CO93X137CW
  • UNII-CO93X137CW
  • 1-(4-(3-amino-1H-indazol-4-yl)phenyl)-3-(2-fluoro-5-methylphenyl)urea
  • Linifanib - ABT-869
  • D0M9QZ
  • LINIFANIB [WHO-DD]
  • C21H18FN5O
  • CHEMBL223360
  • Linifanib (ABT-869)?
  • RG-3635
  • MFCD11840918
  • SCHEMBL93804
  • JSPY-st000257
  • cc-204
  • CHEBI:91435
  • MLS006010276
  • DTXSID40229834
  • RG3635
  • GTPL5657
  • orb1305372
  • QCR-97
  • 2-Fluoro-5-pyridylboronic acid
  • SCHEMBL29375368
  • BDBM21079
  • CTK8F0042
  • AMY7508
  • DTXCID90152325
  • EX-A014
  • SYN1002
  • cid_11485656
  • MPVGZUGXCQEXTM-UHFFFAOYSA-N
  • BCPP000446
  • GLXC-90247
  • HMS3244D06
  • HMS3244D10
  • HMS3244D14
  • HMS3295O19
  • HMS3654E03
  • N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl)urea
  • AOB87120
  • BCP01726
  • KS-00000I9Z
  • ZINC6718813
  • ABP000856
  • AN-503
  • HY-50751G
  • NSC764237
  • NSC800783
  • RS0095
  • s1003
  • 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea
  • AKOS015919098
  • ACN-041466
  • AL39324
  • BCP9000220
  • CCG-264767
  • CS-0115
  • NSC-764237
  • NSC-800783
  • PB34634
  • SDCCGSBI-0654273.P002
  • VZ31170
  • CID11485656
  • NCGC00250403-01
  • NCGC00250403-11
  • 4CA-0745
  • AC-24279
  • AJ-56734
  • AK-40846
  • AL 39324
  • AS-16177
  • BC640336
  • HY-50751
  • SC-87820
  • SMR004701346
  • A-741439
  • AB0008062
  • AB1008464
  • RT-011155
  • A2949
  • CS-0626095
  • FT-0670795
  • SW218116-2
  • X7465
  • EC-000.2119
  • J2.388.171C
  • A10025
  • A19393
  • D09635
  • Q-2136
  • ABT-869(Linifanib)/AL-39324,RG3635/
  • ABT869, Linifanib, AL-39324, RG3635
  • A741439
  • N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea
  • Q6554172
  • S06-0034
  • BRD-K99749624-001-01-3
  • BRD-K99749624-001-07-0
  • 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methyl-phenyl)urea
  • 3-[4-(3-amino-1H-indazol-4-yl)phenyl]-1-(2-fluoro-5-methylphenyl)urea
  • multitargeted receptor tyrosine kinase inhibitor ABT-869
  • N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N1-(2-fluoro-5-methylphenyl)urea
  • Urea, N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)-
  • B0084-151820
  • 1-(2-Fluoro-5-methylphenyl)-3-[4-(3-amino-1H-indazole-4-yl)phenyl]urea
  • 1-[4-(3-Amino-1H-indazole-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea
  • 1-[4-(3-azanyl-1H-indazol-4-yl)phenyl]-3-(2-fluoranyl-5-methyl-phenyl)urea
  • N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl)urea; ABT 869
  • N-[4-(3-Amino-1H-indazole-4-yl)phenyl]-N -(2-fluoro-5-methylphenyl)urea
  • 681-638-2